12-77831655-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001024383.2(NAV3):c.194G>T(p.Gly65Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,613,688 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001024383.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAV3 | NM_001024383.2 | c.194G>T | p.Gly65Val | missense_variant | 1/40 | ENST00000397909.7 | NP_001019554.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAV3 | ENST00000397909.7 | c.194G>T | p.Gly65Val | missense_variant | 1/40 | 1 | NM_001024383.2 | ENSP00000381007 | ||
NAV3 | ENST00000536525.6 | c.194G>T | p.Gly65Val | missense_variant | 1/39 | 1 | ENSP00000446132 | P1 | ||
NAV3 | ENST00000549464.5 | c.194G>T | p.Gly65Val | missense_variant | 1/10 | 5 | ENSP00000446628 | |||
NAV3 | ENST00000550042.2 | c.73-108664G>T | intron_variant | 5 | ENSP00000489639 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000804 AC: 2AN: 248764Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134944
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461536Hom.: 0 Cov.: 33 AF XY: 0.00000413 AC XY: 3AN XY: 727076
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 27, 2022 | The c.194G>T (p.G65V) alteration is located in exon 1 (coding exon 1) of the NAV3 gene. This alteration results from a G to T substitution at nucleotide position 194, causing the glycine (G) at amino acid position 65 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at